Andrea R. Lindell is Director at CHEMED CORP (CHE). They have made 5 open-market trades across 2 companies since 2008, most recently 2026-06-09.
CIK 0001224643
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $41K since 2010, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CHE | 4,578 | $2.5M |
| OCR | 32,297 | — |
| Total | $2.5M |
Shares reported on the most recent Form 4, priced at the 2026-06-10 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CHE | SELL | 2026-06-09 | 2026-06-10 | $447.33 | $603K | +2.4% | +12.6% | +19.9% |
| CHE | SELL | 2024-08-16 | 2024-08-26 | $571.51 | $950K | +0.1% | +4.3% | +0.2% |
| CHE | SELL | 2020-01-23 | 2020-01-27 | $480.06 | $2.0M | +1.6% | -5.9% | -4.8% |
| OCR | BUY | 2010-08-13 | 2010-08-13 | $20.32 | $41K | N/A | N/A | N/A |
| OCR | SELL | 2008-11-05 | 2008-11-10 | $26.58 | $151K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.